Our programs target validated biological mechanisms with unmet clinical need across muscle diseases and age-related decline.

Sarcopenia & Aging

Reversing age-related muscle loss through targeted activation of protein synthesis pathways in skeletal muscle.

Rare Muscle Disease

First-in-class compounds for Duchenne and Becker muscular dystrophy, addressing root-cause biology.

Metabolic Muscle Dysfunction

Targeting insulin resistance and mitochondrial dysfunction in muscle — a key driver of type 2 diabetes progression.